Rchr
J-GLOBAL ID：200901043788587901
Update date: Aug. 29, 2020
Inukai Kouichi
イヌカイ コウイチ | Inukai Kouichi
MISC (12)：
Kenta Imai, Kouichi Inukai, Yuichi Ikegami, Takuya Awata, Shigehiro Katayama. LKB1, an upstream AMPK kinase, regulates glucose and lipid metabolism in cultured liver and muscle cells. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2006. 351. 3. 595-601
A Kushiyama, N Shojima, T Ogihara, K Inukai, H Sakoda, M Fujishiro, Y Fukushima, M Anai, H Ono, N Horike, et al. Resistin-like molecule beta activates MAPKs, suppresses insulin signaling in hepatocytes, and induces diabetes, hyperlipidemia, and fatty liver in transgenic mice on a high fat diet. JOURNAL OF BIOLOGICAL CHEMISTRY. 2005. 280. 51. 42016-42025
K Inukai, T Awata, K Inoue, S Kurihara, Y Nakashima, M Watanabe, T Sawa, N Takata, S Katayama. Identification of a novel WFS1 mutation (AFF344-345ins) in Japanese patients with Wolfram syndrome. DIABETES RESEARCH AND CLINICAL PRACTICE. 2005. 69. 2. 136-141
T Awata, S Kurihara, N Takata, T Neda, H Iizuka, T Ohkubo, M Osaki, M Watanabe, Y Nakashima, K Inukai, et al. Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2005. 333. 3. 679-685
K Inukai, M Watanabe, Y Nakashima, T Sawa, N Takata, M Tanaka, H Kashiwabara, K Yokota, M Suzuki, S Kurihara, et al. Efficacy of glimepiride in Japanese type 2 diabetic subjects. DIABETES RESEARCH AND CLINICAL PRACTICE. 2005. 68. 3. 250-257
ｍore...
Work history (4)：
2007 - 2008 Saitama Medical University Internal Medicine (Endocrinology and Diabetes), Faculty of Medicine
2008 - - 埼玉医科大学 医学部中央研究施設 准教授
2000 - 2007 Saitama Medical University Internal Medicine (Endocrinology and Diabetes), Faculty of Medicine
Saitama Medical University Faculty of Medicine Associate Professor
Awards (1)：
2005 - 丸木記念特別奨学研究費B
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM
